{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00004",
  "type" : "Drug",
  "alternateName" : "Diphtheria toxin precursor",
  "description" : "A recombinant DNA-derived cytotoxic protein composed of the amino acid sequences for diphtheria toxin fragments A and B (Met 1-Thr 387)-His followed by the sequences for interleukin-2 (IL-2; Ala 1-Thr 133). It is produced in an E. coli expression system.",
  "doseSchedule" : "150 ug/mL Injection, solution form with intravenous route",
  "legalStatus" : "investigational",
  "mechanismOfAction" : "Denileukin diftitox binds to the high-affinity IL-2 receptor complex. The IL-2 receptor (Tac) subunit is expressed on activated but not resting lymphocytes. The diphtheria toxin associated with Ontak then selectively kills the IL-2 bearing cells.",
  "name" : "Denileukin diftitox",
  "schema:sameAs" : "https://www.drugbank.ca/drugs/DB00004",
  "schema:url" : "https://www.drugbank.ca/drugs/DB00004"
}